KR102115863B1 - 당뇨병 또는 당뇨병 전증을 관리하기 위한 조성물 및 방법 - Google Patents

당뇨병 또는 당뇨병 전증을 관리하기 위한 조성물 및 방법 Download PDF

Info

Publication number
KR102115863B1
KR102115863B1 KR1020147035153A KR20147035153A KR102115863B1 KR 102115863 B1 KR102115863 B1 KR 102115863B1 KR 1020147035153 A KR1020147035153 A KR 1020147035153A KR 20147035153 A KR20147035153 A KR 20147035153A KR 102115863 B1 KR102115863 B1 KR 102115863B1
Authority
KR
South Korea
Prior art keywords
beverage
delete delete
subject
minutes
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020147035153A
Other languages
English (en)
Korean (ko)
Other versions
KR20150013792A (ko
Inventor
크리스토퍼 왈터 리치티
피터 리차드 와인터 베스트
자네나 프랜시스 베스트
코트프리드 리치티
Original Assignee
옴니블렌드 이노베이션 피티와이 엘티디
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012904029A external-priority patent/AU2012904029A0/en
Application filed by 옴니블렌드 이노베이션 피티와이 엘티디 filed Critical 옴니블렌드 이노베이션 피티와이 엘티디
Publication of KR20150013792A publication Critical patent/KR20150013792A/ko
Application granted granted Critical
Publication of KR102115863B1 publication Critical patent/KR102115863B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/185Vegetable proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/38Other non-alcoholic beverages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/385Concentrates of non-alcoholic beverages
    • A23L2/39Dry compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • A23L2/66Proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1412Containers with closing means, e.g. caps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D25/00Details of other kinds or types of rigid or semi-rigid containers
    • B65D25/54Inspection openings or windows
    • B65D25/56Inspection openings or windows with means for indicating level of contents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/50Polysaccharides, gums
    • A23V2250/502Gums
    • A23V2250/5074Psyllium
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/54Proteins
    • A23V2250/542Animal Protein
    • A23V2250/5424Dairy protein
    • A23V2250/54252Whey protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/801Pediatric

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Mechanical Engineering (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
KR1020147035153A 2012-05-23 2013-05-22 당뇨병 또는 당뇨병 전증을 관리하기 위한 조성물 및 방법 Active KR102115863B1 (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261650769P 2012-05-23 2012-05-23
US61/650,769 2012-05-23
AU2012904029 2012-09-14
AU2012904029A AU2012904029A0 (en) 2012-09-14 Composition and method for management of diabetes or pre-diabetes
AU2013204801A AU2013204801B2 (en) 2012-05-23 2013-04-12 Composition and method for management of diabetes or pre-diabetes
AU2013204801 2013-04-12
PCT/AU2013/000537 WO2013173874A2 (en) 2012-05-23 2013-05-22 Composition and method for management of diabetes or pre-diabetes

Publications (2)

Publication Number Publication Date
KR20150013792A KR20150013792A (ko) 2015-02-05
KR102115863B1 true KR102115863B1 (ko) 2020-05-28

Family

ID=49624403

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147035153A Active KR102115863B1 (ko) 2012-05-23 2013-05-22 당뇨병 또는 당뇨병 전증을 관리하기 위한 조성물 및 방법

Country Status (11)

Country Link
US (2) US9675553B2 (https=)
EP (1) EP2852298B1 (https=)
JP (1) JP6414897B2 (https=)
KR (1) KR102115863B1 (https=)
CN (1) CN105578903B (https=)
AU (1) AU2013204801B2 (https=)
CA (1) CA2874034C (https=)
IL (1) IL235855A (https=)
NZ (1) NZ701302A (https=)
WO (1) WO2013173874A2 (https=)
ZA (1) ZA201408480B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1223034A1 (zh) * 2013-11-19 2017-07-21 Omniblend Innovation Pty Ltd 用於治疗2型糖尿病的方法和养生方案
US20180139987A1 (en) * 2015-04-23 2018-05-24 Omniblend Innovation Pty Ltd Pharmaceutical powder composition and its use in the control of post-prandial glycaemic profile
AU2021305336B2 (en) * 2020-07-10 2025-02-06 C° Change Surgical Llc Injectable slush feed supply

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003105882A1 (en) 2002-06-13 2003-12-24 Novartis Nutrition Ag Composition comprising viscous fibers and viscosity-lowering proteins
JP2005204943A (ja) * 2004-01-22 2005-08-04 Shusuke Nagai カクテルシェーカー

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191102A (en) * 1978-07-25 1982-03-09 Wellcome Found Pharmaceutical formulations of galactomannan
CA1201321A (en) 1981-12-22 1986-03-04 Anne-Marie Dahlen Protein-fruit drink
CA1221575A (en) 1983-10-17 1987-05-12 John A. Colliopoulos Psyllium mucilloid products
US4921877A (en) 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
US5104676A (en) 1991-06-27 1992-04-14 Abbott Laboratories Weight control product
US5547275A (en) * 1995-08-17 1996-08-20 Dart Industries Inc. Shaker and blender
US5747532A (en) 1995-11-21 1998-05-05 Medinox, Inc. Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
US6139900A (en) * 1998-08-11 2000-10-31 North Carolina State University Method of forming whey protein products
GB9927603D0 (en) 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
US6365176B1 (en) 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
US20040087514A1 (en) * 2002-09-06 2004-05-06 Hughes Thomas E Nutritional compositions
US7744930B2 (en) 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
CA2507764A1 (en) 2002-12-20 2004-07-08 Unilever Plc Blood glucose regulating composition
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US7988989B2 (en) * 2003-05-09 2011-08-02 Freedom Health, Llc Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
US7824706B2 (en) * 2003-05-09 2010-11-02 Freedom Health, Llc Dietary supplement and method for the treatment of digestive tract ulcers in equines
BRPI0412189A (pt) 2003-06-30 2006-08-22 Nestec Sa composição para tratar e/ou prevenir disfunções associadas à diabetes melito do tipo 2
GB2432772B (en) * 2005-11-30 2011-06-01 Sis Improvements in and relating to nutritional products
PL1983849T3 (pl) 2006-01-20 2013-09-30 Innova Food Ab Kompozycja spożywcza zawierająca aminokwasy
US7977319B1 (en) 2006-04-03 2011-07-12 Scott David Levine Ultra-high fiber supplement and method of reducing weight, cardiovascular risks and ingested toxins
EP2003991A1 (en) 2006-04-12 2008-12-24 DSM IP Assets B.V. Novel nutraceutical compositions
US8518469B2 (en) 2007-06-12 2013-08-27 Kraft Foods Group Brands Llc Powdered beverage composition
AU2009222965B2 (en) 2008-03-13 2014-10-02 Immuron Limited Immuno-modulating compositions for the treatment of immune-mediated disorders
CA2676518A1 (en) 2008-08-29 2010-02-28 Kraft Foods Global Brands Llc Whey protein pre-load
EA024697B1 (ru) 2009-04-27 2016-10-31 Иммурон Лимитед Применение композиции, содержащей обогащенный анти-lps-антителами иммуноглобулиновый препарат, для лечения заболеваний печени
EP2512460A4 (en) * 2009-12-18 2015-01-21 Exodos Life Sciences Ltd Partnership METHOD AND COMPOSITIONS FOR STABLE LIQUID ACTIVE FORMULATIONS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003105882A1 (en) 2002-06-13 2003-12-24 Novartis Nutrition Ag Composition comprising viscous fibers and viscosity-lowering proteins
JP2010254702A (ja) * 2002-06-13 2010-11-11 Novartis Ag 粘稠性繊維と粘度低下性タンパク質とを含む組成物
JP2005204943A (ja) * 2004-01-22 2005-08-04 Shusuke Nagai カクテルシェーカー

Also Published As

Publication number Publication date
AU2013204801B2 (en) 2014-11-06
EP2852298A4 (en) 2016-07-06
CN105578903A (zh) 2016-05-11
ZA201408480B (en) 2015-12-23
IL235855A (en) 2017-09-28
US20170189332A1 (en) 2017-07-06
IL235855A0 (en) 2015-01-29
HK1208783A1 (en) 2016-03-18
JP6414897B2 (ja) 2018-10-31
WO2013173874A3 (en) 2015-06-11
US20150164793A1 (en) 2015-06-18
EP2852298A2 (en) 2015-04-01
WO2013173874A2 (en) 2013-11-28
NZ701302A (en) 2017-07-28
CA2874034A1 (en) 2013-11-28
EP2852298B1 (en) 2018-11-14
KR20150013792A (ko) 2015-02-05
CA2874034C (en) 2021-05-25
US9675553B2 (en) 2017-06-13
US9775801B2 (en) 2017-10-03
CN105578903B (zh) 2018-08-07
JP2015533076A (ja) 2015-11-19

Similar Documents

Publication Publication Date Title
EP3263118B1 (en) Flaxseeds for body weight management
WO2015200842A1 (en) Composition comprising metformin and a microbiome modulator
KR102115863B1 (ko) 당뇨병 또는 당뇨병 전증을 관리하기 위한 조성물 및 방법
AU2014353872B2 (en) Composition and method for control of post-prandial glucose
HK1208783B (en) Composition for management of diabetes or pre-diabetes
US20180139987A1 (en) Pharmaceutical powder composition and its use in the control of post-prandial glycaemic profile
US20160287515A1 (en) Regimen and method for treatment of type 2 diabetes
HK1222993B (en) Composition and method for control of post-prandial glucose
NZ720647B2 (en) Composition and method for control of post-prandial glucose
HK1248582A1 (en) Flaxseeds for body weight management

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20141215

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20180521

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20190927

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20200422

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20200521

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20200521

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20230517

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20240513

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20250513

Start annual number: 6

End annual number: 6